Assays targeting the polA gene demonstrate similar specificity (98%–100%) and have been performed on lesion exudates of primary and secondary syphilis as well as CSF from neurosyphilis cases (109,110,189,203,204,210,211). This evidence concerns the gene POLA1 and neurosyphilis.